Literature DB >> 1373292

IL-1 production as a regulator of G-CSF and IL-6 production in CSF-producing cell lines.

A Suzuki1, T Takahashi, Y Okuno, R Tsuyuoka, M Fukumoto, K Nakamura, H Imura.   

Abstract

We previously demonstrated that colony stimulating factor (CSF)-producing cell lines co-produce interleukin-1 (IL-1) and IL-6 in addition to CSFs. In the present study, we examined the role of IL-1 production in three human tumour cell lines producing granulocyte (G)-CSF, IL-1 and IL-6. Addition of anti-human IL-1 alpha antiserum to the culture caused a 90-62% reduction of G-CSF and a 85-44% reduction of IL-6 production, respectively, as evaluated by enzyme immunoassay in all three cell lines. The decrease of G-CSF and IL-6 production by the anti-IL-1 alpha antiserum was also confirmed at the level of mRNA expression. The anti-IL-1 alpha antiserum did not affect the growth of these cell lines. Excess recombinant IL-1 alpha exogenously added to the culture enhanced G-CSF and IL-6 production in all three cell lines. However, IL-1 alpha had little effect on the growth of these three cell lines. Neither anti-IL-6 nor anti-G-CSF antibodies affected the production of the other cytokines. These results indicate that IL-1 alpha regulates G-CSF and IL-6 production in these tumour cell lines, and suggest that the IL-1 production plays an important role in CSF-producing tumours.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373292      PMCID: PMC1977563          DOI: 10.1038/bjc.1992.106

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

2.  Interleukin 1 and poly(rI).poly(rC) induce production of granulocyte CSF, macrophage CSF, and granulocyte-macrophage CSF by human endothelial cells.

Authors:  W E Fibbe; M R Daha; P S Hiemstra; N Duinkerken; E Lurvink; P Ralph; B W Altrock; K Kaushansky; R Willemze; J H Falkenburg
Journal:  Exp Hematol       Date:  1989-03       Impact factor: 3.084

3.  Paraneoplastic syndrome of hypercalcemia and leukocytosis caused by squamous carcinoma cells (T3M-1) producing parathyroid hormone-related protein, interleukin 1 alpha, and granulocyte colony-stimulating factor.

Authors:  K Sato; Y Fujii; T Kakiuchi; K Kasono; H Imamura; Y Kondo; H Mano; T Okabe; S Asano; F Takaku
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701

4.  Regulation of cytokine and growth factor gene expression in human bone marrow stromal cells transformed with simian virus 40.

Authors:  J L Slack; J Nemunaitis; D F Andrews; J W Singer
Journal:  Blood       Date:  1990-06-15       Impact factor: 22.113

5.  Multiple elements in the promoter of granulocyte colony-stimulating factor gene regulate its constitutive expression in human carcinoma cells.

Authors:  M Nishizawa; M Tsuchiya; R Watanabe-Fukunaga; S Nagata
Journal:  J Biol Chem       Date:  1990-04-05       Impact factor: 5.157

6.  Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies.

Authors:  T Matsuda; T Hirano; T Kishimoto
Journal:  Eur J Immunol       Date:  1988-06       Impact factor: 5.532

7.  Interleukin-1 (22-K factor) induces release of granulocyte-macrophage colony-stimulating activity from human mononuclear phagocytes.

Authors:  W E Fibbe; J van Damme; A Billiau; P J Voogt; N Duinkerken; P M Kluck; J H Falkenburg
Journal:  Blood       Date:  1986-12       Impact factor: 22.113

8.  Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor.

Authors:  S Nagata; M Tsuchiya; S Asano; Y Kaziro; T Yamazaki; O Yamamoto; Y Hirata; N Kubota; M Oheda; H Nomura
Journal:  Nature       Date:  1986 Jan 30-Feb 5       Impact factor: 49.962

9.  A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family.

Authors:  S Akira; H Isshiki; T Sugita; O Tanabe; S Kinoshita; Y Nishio; T Nakajima; T Hirano; T Kishimoto
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

10.  Co-production of interleukin-1 and interleukin-6 in tumor cell lines elaborating colony-stimulating factors.

Authors:  Y Okuno; T Takahashi; A Suzuki; M Fukumoto; K Nakamura; H Imura
Journal:  Jpn J Cancer Res       Date:  1991-08
View more
  9 in total

Review 1.  IL-17A-producing neutrophil-regulatory Tn lymphocytes.

Authors:  Klaus Ley; Emily Smith; Matthew A Stark
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Dysregulated neutrophil responses and neutrophil extracellular trap formation and degradation in PAPA syndrome.

Authors:  Pragnesh Mistry; Carmelo Carmona-Rivera; Amanda K Ombrello; Patrycja Hoffmann; Nickie L Seto; Anne Jones; Deborah L Stone; Faiza Naz; Philip Carlucci; Stefania Dell'Orso; Gustavo Gutierrez-Cruz; Hong-Wei Sun; Daniel L Kastner; Ivona Aksentijevich; Mariana J Kaplan
Journal:  Ann Rheum Dis       Date:  2018-08-21       Impact factor: 19.103

3.  Epidermal ablation of Dlx3 is linked to IL-17-associated skin inflammation.

Authors:  Joonsung Hwang; Ryosuke Kita; Hyouk-Soo Kwon; Eung Ho Choi; Seung Hun Lee; Mark C Udey; Maria I Morasso
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

4.  Establishment of a human anaplastic thyroid cancer cell line secreting granulocyte colony-stimulating factor in response to cytokines.

Authors:  Y Oka; T Kobayashi; S Fujita; N Matsuura; S Okamoto; H Asakawa; A Murata; T Mori
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-07       Impact factor: 2.416

5.  A case of granulocyte-colony stimulating factor-producing hepatocellular carcinoma confirmed by immunohistochemistry.

Authors:  Satoru Joshita; Koh Nakazawa; Shoichiro Koike; Atsushi Kamijo; Kiyoshi Matsubayashi; Hideharu Miyabayashi; Kiyoshi Furuta; Kiyoshi Kitano; Kaname Yoshizawa; Eiji Tanaka
Journal:  J Korean Med Sci       Date:  2010-02-17       Impact factor: 2.153

6.  Systemic dysfunction and plasticity of the immune macroenvironment in cancer models.

Authors:  Breanna M Allen; Kamir J Hiam; Cassandra E Burnett; Anthony Venida; Rachel DeBarge; Iliana Tenvooren; Diana M Marquez; Nam Woo Cho; Yaron Carmi; Matthew H Spitzer
Journal:  Nat Med       Date:  2020-05-25       Impact factor: 53.440

7.  The peripheral myeloid expansion driven by murine cancer progression is reversed by radiation therapy of the tumor.

Authors:  Marka R Crittenden; Talicia Savage; Benjamin Cottam; Keith S Bahjat; William L Redmond; Shelly Bambina; Melissa Kasiewicz; Pippa Newell; Andrew M Jackson; Michael J Gough
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

Review 8.  Understanding the Cellular Origin of the Mononuclear Phagocyte System Sheds Light on the Myeloid Postulate of Immune Paralysis in Sepsis.

Authors:  Lionel Franz Poulin; Corentin Lasseaux; Mathias Chamaillard
Journal:  Front Immunol       Date:  2018-04-24       Impact factor: 7.561

9.  The IL-1 Receptor Is Required to Maintain Neutrophil Viability and Function During Aspergillus fumigatus Airway Infection.

Authors:  Benjamin Awr Ralph; Melanie Lehoux; Hanna Ostapska; Brendan D Snarr; Alayna K Caffrey-Carr; Richard Fraser; Maya Saleh; Joshua J Obar; Salman T Qureshi; Donald C Sheppard
Journal:  Front Immunol       Date:  2021-07-12       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.